AbbVie ABBV Institutional Ownership

Updated Oct 11, 2026

AbbVie Inc. (NYSE:ABBV) had 4,161 institutional holders reporting a position on Form 13F for the quarter ended June 30, 2026.

• Together they owned 74.90% of the outstanding stock in Q2 2026, up from 72.94% a quarter earlier.
• Total holdings of ABBV shares rose 2.63% from Q1 2026, and the holder count rose 11.85% from Q2 2025.
• Of these 4,161 holders, 2,194 added to their positions, 1,500 reduced their stakes and 467 left their positions unchanged.
• The aggregate institutional position in AbbVie was 1.33Bn shares at the end of Q2 2026, up 34Mn from the prior quarter and up 86.09Mn from a year earlier.
• As of June 30, 2026, BlackRock, Inc. held the largest stake in AbbVie with 149.49Mn shares, or 8.45% of shares outstanding.
• Among holders that already owned AbbVie, the biggest buyers in Q2 2026 were Franklin Templeton Inc (+5.37Mn shares), Capital World Investors (+3.34Mn shares), Marshall Wace, LLP (+2.99Mn shares), SG Americas Securities, LLC (+2.85Mn shares) and Citadel Advisors LLC (+2.68Mn shares).
• Among holders that kept a stake in AbbVie, the biggest sellers in Q2 2026 were JPMorgan Chase & Co (-8.88Mn shares), Bank of America Corp (-2.7Mn shares), Corient Private Wealth LP (-2.19Mn shares), Healthcare of Ontario Pension Plan Trust Fund (-1.87Mn shares) and Wellington Management Group LLP (-1.84Mn shares).
• Business Quant data shows the 10 biggest positions in AbbVie as of Q2 2026 were held by BlackRock, Inc. (149.49Mn shares), Vanguard Capital Management LLC (115.4Mn shares), State Street Corp (82.6Mn shares), Vanguard Portfolio Management LLC (48.48Mn shares), JPMorgan Chase & Co (47.86Mn shares), Geode Capital Management, LLC (47Mn shares), Morgan Stanley (38.9Mn shares), Capital Research Global Investors (30.1Mn shares), Norges Bank (25.55Mn shares) and Bank of America Corp (21.24Mn shares).